Aliases & Classifications for Vaginitis

MalaCards integrated aliases for Vaginitis:

Name: Vaginitis 12 40 41 14 69
Infective Vaginitis 69

Classifications:



Summaries for Vaginitis

MedlinePlus : 40 What is vaginitis? Vaginitis, also called vulvovaginitis, is an inflammation or infection of the vagina. It can also affect the vulva, which is the external part of a woman's genitals. Vaginitis can cause itching, pain, discharge, and odor. Vaginitis is common, especially in women in their reproductive years. It usually happens when there is a change in the balance of bacteria or yeast that are normally found in your vagina. There are different types of vaginitis, and they have different causes, symptoms, and treatments. What are the different causes of vaginitis? Bacterial vaginosis (BV) is the most common vaginal infection in women ages 15-44. It happens when there is an imbalance between the "good" and "harmful" bacteria that are normally found in a woman's vagina. Many things can change the balance of bacteria, including Taking antibiotics Douching Using an intrauterine device (IUD) Having unprotected sex with a new partner Having many sexual partners Yeast infections (candidiasis) happen when too much candida grows in the vagina. Candida is the scientific name for yeast. It is a fungus that lives almost everywhere, including in your body. You may have too much growing in the vagina because of Antibiotics Pregnancy Diabetes, especially if it is not well-controlled Corticosteroid medicines Trichomoniasis can also cause vaginitis. Trichomoniasis is a common sexually transmitted disease. It is caused by a parasite. You can also have vaginitis if you are allergic or sensitive to certain products that you use. Examples include vaginal sprays, douches, spermicides, soaps, detergents, or fabric softeners. They can cause burning, itching, and discharge. Hormonal changes can also cause vaginal irritation. Examples are when you are pregnant or breastfeeding, or when you have gone through menopause. Sometimes you can have more than one cause of vaginitis at the same time. What are the symptoms of vaginitis? The symptoms of vaginitis depend on which type you have. With BV, you may not have symptoms. You could have a thin white or gray vaginal discharge. There may be an odor, such as a strong fish-like odor, especially after sex. Yeast infections produce a thick, white discharge from the vagina that can look like cottage cheese. The discharge can be watery and often has no smell. Yeast infections usually cause the vagina and vulva to become itchy and red. You may not have symptoms when you have trichomoniasis. If you do have them, they include itching, burning, and soreness of the vagina and vulva. You may have burning during urination. You could also have gray-green discharge, which may smell bad. How is the cause of vaginitis diagnosed? To find out the cause of your symptoms, your health care provider may Ask you about your health history Do a pelvic exam Look for vaginal discharge, noting its color, qualities, and any odor Study a sample of your vaginal fluid under a microscope In some cases, you may need more tests. What are the treatments for vaginitis? The treatment depends on which type of vaginitis you have. BV is treatable with antibiotics. You may get pills to swallow, or cream or gel that you put in your vagina. During treatment, you should use a condom during sex or not have sex at all. Yeast infections are usually treated with a cream or with medicine that you put inside your vagina. You can buy over-the-counter treatments for yeast infections, but you need to be sure that you do have a yeast infection and not another type of vaginitis. See your health care provider if this is the first time you have had symptoms. Even if you have had yeast infections before, it is a good idea to call your health care provider before using an over-the-counter treatment. The treatment for trichomoniasis is usually a single-dose antibiotic. Both you and your partner(s) should be treated, to prevent spreading the infection to others and to keep from getting it again. If your vaginitis is due to an allergy or sensitivity to a product, you need to figure out which product is causing the problem. It could be a product that you started using recently. Once you figure it out, you should stop using the product. If the cause of your vaginitis is a hormonal change, your health care provider may give you estrogen cream to help with your symptoms. Can vaginitis cause other health problems? It is important to treat BV and trichomoniasis, because having either of them can increase your risk for getting HIV or another sexually transmitted disease. If you are pregnant, BV or trichomoniasis can increase your risk for preterm labor and preterm birth. How can I prevent vaginitis? To help prevent vaginitis Do not douche or use vaginal sprays Use a condom when having sex Avoid clothes that hold in heat and moisture Wear cotton underwear

MalaCards based summary : Vaginitis, also known as infective vaginitis, is related to postmenopausal atrophic vaginitis and bacterial vaginosis, and has symptoms including vaginal pain or burning, vaginal discomfort and vaginal odor. An important gene associated with Vaginitis is ESR1 (Estrogen Receptor 1), and among its related pathways/superpathways are Pathways in cancer and Allograft rejection. The drugs Desogestrel and Estradiol have been mentioned in the context of this disorder. Affiliated tissues include testes, uterus and colon, and related phenotypes are Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435) and cardiovascular system

Wikipedia : 72 Vaginitis is inflammation of the vagina. In most cases, it is a symptom of an infection of the... more...

Related Diseases for Vaginitis

Diseases related to Vaginitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 557)
# Related Disease Score Top Affiliating Genes
1 postmenopausal atrophic vaginitis 34.1 AR ESR1 ESR2
2 bacterial vaginosis 31.5 CXCL8 IL1B IL6 PRF1
3 chorioamnionitis 31.4 CXCL8 IL1B IL6
4 chlamydia 31.4 CXCL8 IL1B IL6
5 vaginal disease 30.7 CXCL8 EZR IL1B IL6 PRF1 SERPINH1
6 endometritis 30.1 ESR1 IL1B IL6
7 transsexualism 29.8 AR ESR2
8 vulvar vestibulitis syndrome 29.7 ESR1 IL1B
9 toxic shock syndrome 29.7 CXCL8 IL1B IL6
10 female reproductive system disease 29.6 CXCL8 ESR1 ESR2 IL1B IL6 SERPINH1
11 peritonitis 29.5 CXCL8 IL1B IL6
12 endometriosis of ovary 29.5 ESR1 ESR2
13 endometriosis 29.3 CXCL8 ESR1 ESR2 IL1B IL6
14 streptococcal toxic-shock syndrome 29.3 CXCL8 IL6
15 cervical incompetence 29.2 IL6 SERPINH1
16 preterm premature rupture of the membranes 29.1 CXCL8 IL6 SERPINH1
17 prostatitis 29.1 CXCL8 IL1B IL6
18 meningitis 29.1 CXCL8 IL1B IL6
19 pneumonia 29.0 CXCL8 IL1B IL6
20 bacteriuria 29.0 CXCL8 IL6 PRF1
21 pyelonephritis 28.9 CXCL8 IL1B IL6
22 appendicitis 28.9 CXCL8 IL1B IL6
23 gingivitis 28.9 CXCL8 IL1B IL6
24 esophagitis 28.9 CXCL8 IL1B IL6
25 contact dermatitis 28.9 CXCL8 IL1B IL6
26 ulcerative colitis 28.6 ABCB1 CXCL8 IL1B IL6
27 colitis 28.6 ABCB1 CXCL8 IL1B IL6
28 osteoporosis 28.5 AR ESR1 ESR2 IL1B IL6
29 uterine anomalies 28.4 CXCL8 ESR1 IL1B IL6 SERPINH1
30 vaginal cancer 12.4
31 vaginal discharge 12.3
32 vaginal atresia 12.2
33 vaginal adenosarcoma 12.2
34 vaginal yolk sac tumor 12.0
35 vaginal squamous papilloma 12.0
36 vaginal spindle cell epithelioma 11.9
37 vaginal carcinosarcoma 11.9
38 transverse vaginal septum 11.9
39 longitudinal vaginal septum 11.9
40 uterus bicornis bicollis with partial vaginal septum and unilateral hematocolpos with ipsilateral renal agenesis 11.9
41 vaginal mullerian papilloma 11.8
42 vaginal adenoma 11.8
43 vaginal tubulovillous adenoma 11.8
44 vaginal benign neoplasm 11.8
45 vaginal glandular tumor 11.8
46 vaginal squamous tumor 11.8
47 vaginal villous adenoma 11.8
48 vaginal tubular adenoma 11.8
49 vulvovaginitis 11.8
50 benign vaginal carcinosarcoma 11.8

Graphical network of the top 20 diseases related to Vaginitis:



Diseases related to Vaginitis

Symptoms & Phenotypes for Vaginitis

UMLS symptoms related to Vaginitis:


vaginal pain or burning, vaginal discomfort, vaginal odor, vaginal pruritus, leukorrhea

GenomeRNAi Phenotypes related to Vaginitis according to GeneCards Suite gene sharing:

25
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435) GR00104-A-0 8.8 CXCL8 ESR1 ESR2

MGI Mouse Phenotypes related to Vaginitis:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.13 PRF1 SERPINH1 SPTB IL1B ESR1 IL6
2 growth/size/body region MP:0005378 10.13 PRF1 SERPINH1 SPTB IL6 IL1B ESR1
3 hematopoietic system MP:0005397 10.1 PRF1 SH2D1A SPTB IL1B ESR1 IL6
4 immune system MP:0005387 10.07 PRF1 SH2D1A SPTB IL1B ESR1 IL6
5 digestive/alimentary MP:0005381 10 SERPINH1 ESR1 IL6 ABCB1 ESR2 EZR
6 mortality/aging MP:0010768 9.96 IL6 PRF1 SERPINH1 SPTB AR IL1B
7 liver/biliary system MP:0005370 9.87 PRF1 SPTB ESR1 IL6 ABCB1 ESR2
8 neoplasm MP:0002006 9.63 PRF1 IL6 IL1B ESR1 ESR2 AR
9 nervous system MP:0003631 9.61 IL6 PRF1 SERPINH1 SPTB AR IL1B
10 reproductive system MP:0005389 9.17 IL6 PRF1 SPTB AR ESR1 ABCB1

Drugs & Therapeutics for Vaginitis

Drugs for Vaginitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 182)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Desogestrel Approved Phase 4 54024-22-5 40973
2
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-28-2 5757
3
Ethinyl Estradiol Approved Phase 4,Phase 2 57-63-6 5991
4
Etonogestrel Approved, Investigational Phase 4 54048-10-1 6917715 40976
5
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
6
Metronidazole Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 443-48-1 4173
7
Clindamycin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Early Phase 1 18323-44-9 29029
8
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 22916-47-8 4189
9
Nystatin Approved, Vet_approved Phase 4,Phase 3 1400-61-9 11953884
10
Fluconazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 86386-73-4 3365
11
Neomycin Approved, Vet_approved Phase 4,Phase 3 1404-04-2 8378
12
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741 24759
13
Clotrimazole Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 23593-75-1 2812
14
Azithromycin Approved Phase 4,Phase 3 83905-01-5 53477736 447043 55185
15
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
16
Tinidazole Approved, Investigational Phase 4,Phase 3,Phase 2,Early Phase 1 19387-91-8 5479
17
Dequalinium Approved, Investigational Phase 4,Phase 3 6707-58-0
18
Terconazole Approved Phase 4,Phase 3,Early Phase 1 67915-31-5 441383
19
Progesterone Approved, Vet_approved Phase 4,Phase 2 57-83-0 5994
20
Ephedrine Approved Phase 4,Phase 2,Phase 3 299-42-3 9294
21
Pseudoephedrine Approved Phase 4,Phase 2,Phase 3 90-82-4 7028
22
Norethindrone Approved Phase 4,Phase 2 68-22-4 6230
23 Cranberry Approved, Investigational, Nutraceutical Phase 4
24 Apricot Approved, Nutraceutical Phase 4
25 Contraceptive Agents Phase 4,Phase 3,Phase 2,Phase 1
26 Contraceptives, Oral Phase 4,Phase 3,Phase 2
27 Estradiol 17 beta-cypionate Phase 4,Phase 3,Phase 2,Phase 1
28 Estradiol 3-benzoate Phase 4,Phase 3,Phase 2,Phase 1
29 Estradiol valerate Phase 4,Phase 3,Phase 2,Phase 1 979-32-8
30 Estrogens Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
31 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
32 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
33 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
34 Polyestradiol phosphate Phase 4,Phase 3,Phase 2,Phase 1
35 Progestins Phase 4,Phase 2
36 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1
37 Antibiotics, Antitubercular Phase 4,Phase 2,Not Applicable
38 Antidotes Phase 4
39 Anti-Infective Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
40 Antioxidants Phase 4
41 Antiparasitic Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
42 Antiprotozoal Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
43 Antiviral Agents Phase 4,Phase 2
44 Expectorants Phase 4
45 N-monoacetylcystine Phase 4
46 Protective Agents Phase 4,Phase 2
47 Respiratory System Agents Phase 4,Phase 2,Phase 3
48 Clindamycin palmitate Phase 4,Phase 3,Phase 2,Early Phase 1
49 Clindamycin phosphate Phase 4,Phase 3,Phase 2,Early Phase 1
50 Antifungal Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 258)

# Name Status NCT ID Phase Drugs
1 Probiotics Capsule as Supplemental Therapy for Group B Streptococci Infection and Vaginitis During Pregnancy Unknown status NCT01779193 Phase 4
2 Effect of the Etonogestrel 0.12mg/Ethinyl Estradiol 0.015mg Vaginal Ring on Vaginal Innate and Inflammatory Biomarkers Unknown status NCT01448291 Phase 4 Etonogestrel /Ethinyl Estradiol Contraceptive Vaginal Ring
3 Role of N-Acetylcysteine in Treatment of Bacterial Vaginosis Unknown status NCT01841411 Phase 4 N-Acetyl cysteine;Metronidazole + N-Acetyl cysteine;metronidazole
4 Probiotic Versus Placebo as Adjuvant for Bacterial Vaginosis Treatment During Pregnancy Unknown status NCT01558388 Phase 4 Lactobacillus acidophilus;Placebo
5 Open Study of the Efficacy of the Local Treatment With Polygynax of Bacterial and/or Mycotic Vaginitis Completed NCT02444481 Phase 4 Polygynax combinaison of polymyxin, Neomycin and Nystatin
6 Oral Low-molecular Weight Hyaluronic Acid in the Treatment of Atrophic Vaginitis Completed NCT02014428 Phase 4 Placebo
7 DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative Women Completed NCT01874158 Phase 4
8 Comparison of Two Topical Formulations Containing Clindamycin and Clotrimazole in Patients With Vaginal Infections Completed NCT01697826 Phase 4 ClinSupV3 -soft gelatin capsule;ClinSupV3ER- Extended release tablet
9 Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients Completed NCT03032848 Phase 4 Conjugated Estrogen;Promestriene;Estriol;Vaginal Moisturizer - Cream
10 Periodical Presumptive Treatment for the Control of Gonococcal Infections Among Sex Workers Completed NCT01329588 Phase 4 Monthly antibiotic;Monthly placebo
11 Safety and Tolerability of Metronidazole Gel 1.3% Completed NCT02392026 Phase 4 Metronidazole Gel
12 Treatment of Bacterial Vaginosis Combined With Human Lactobacilli Completed NCT01245322 Phase 4 lactobacilli
13 Treatment of Bacterial Vaginosis (BV) With Tinidazole Completed NCT00334633 Phase 4 tinidazole, metronidazole
14 Treatment of Bacterial Vaginosis Completed NCT00324818 Phase 4 metronidazole and azithromycin
15 Lactoserum (Dermacyd Femina®) and Prevention of Recurrence of Bacterial Vaginosis Completed NCT00556179 Phase 4 Lactoserum (Dermacyd Femina®)
16 Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial Vaginosis Completed NCT00642980 Phase 4 Clindamycin;Placebo;Clindamycin
17 Clindamycin to Reduce Preterm Birth in a Low Resource Setting Completed NCT01800825 Phase 4 Clindamycin;Placebo
18 Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis Completed NCT02248506 Phase 4
19 Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis Completed NCT02242695 Phase 4 Fluomizin vaginal tablets;Canesten vaginal tablets
20 Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis Completed NCT02180828 Phase 4 Clotrimazole vaginal tablet;Fluconazole
21 Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis Completed NCT02180100 Phase 4 Terconazole Vaginal Suppository;Fluconazole
22 Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina Completed NCT00194324 Phase 4 Miconazole nitrate
23 Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study Completed NCT00464542 Phase 4 Metronidazole
24 Prevention of Preterm Birth in Pregnant Women at Risk Identified by Ultrasound: Evaluation of Two Treatment Strategies Completed NCT01643980 Phase 4 Vaginal micronized progesterone
25 Honghe Fujie Lotion for the Treatment of Bacterial Vaginosis Recruiting NCT03446443 Phase 4 Honghe Fujie lotion;Metronidazole Suppositories
26 Vaginal and Urinary Microbiome Trial Recruiting NCT02869165 Phase 4 Premarin vaginal cream;Apricot kernel oil
27 Use of Boric Acid in Combination With Probiotics for the Treatment of Vaginal Infections Recruiting NCT02860845 Phase 4 Antibiotic (Clindamycin);Antifungal (Clotrimazole)
28 Treatment Comparison of Antibiotics Versus Vaginal Lactic Acid in Non-pregnant Women With Acute Symptomatic Bacterial Vaginosis Recruiting NCT02042287 Phase 4 Metronidazole
29 The Efficacy and Safety Study of Clindamycin Palmitate Hydrochloride Dispersible Tablet Treatment of Bacterial Vaginosis Recruiting NCT03080740 Phase 4 Clindamycin palmitate hydrochloride dispersible tablet;Metronidazole Tablet
30 The Effect of Norethisterone Enanthate on Recurrent Bacterial Vaginosis Recruiting NCT02905890 Phase 4 Norethisterone enantate
31 Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity Recruiting NCT02445989 Phase 4 NuvaRing
32 Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity Recruiting NCT02432404 Phase 4 NuvaRing
33 Oral Metronidazole With Lactobacillus Vaginal Suppositories to Prevent Recurrence of Bacterial Vaginosis Recruiting NCT03099408 Phase 4 Metronidazole Oral;"Metronidazole" and "Lactobacillus"
34 Colposeptine for the Treatment of Bacterial Vaginosis Terminated NCT01153958 Phase 4 Colposeptine;Metronidazole
35 Saginil in vs. Placebo for Gynecologic Oncology Patients Affected by Vaginitis Unknown status NCT01420510 Phase 2, Phase 3 Adelmidrol vaginal gel;Placebo vaginal gel
36 Safety and Efficacy Study of Gynevac Lactobacillus Vaccine in the Treatment of Bacterial Vaginosis Unknown status NCT02173184 Phase 3
37 A Pilot Open-label Randomized Study of Lactofiltrum in Women With Bacterial Vaginosis Unknown status NCT01089348 Phase 2, Phase 3 Lactofiltrum + Metronidazole;Metronidazole
38 Efficacy and Safety Study of Metronidazole, Nystatin and Dexamethasone Combination Therapy in Bacterial and Fungal Vaginal Infections Unknown status NCT02186145 Phase 3 Association of metronidazole; nystatin and dexamethasone;Flagyl
39 Evaluate Efficacy, Tolerability & Safety of Combination of Clindamycin and Ketoconazole for the Treatment of Mixed-Type Vaginosis, Bacterial Vaginosis and Candidiasis Unknown status NCT00889356 Phase 3 Clindamycin 100mg and Ketoconazole 400mg;Tetracycline 100mg and Amphotericin B 50mg
40 Bacterial Vaginosis Screening and Treatment to Reduce Infective Complications, Abortion and Preterm Delivery Unknown status NCT00491270 Phase 3
41 Va-Sense - Bacterial Vaginosis Once A Week Screening And Treatment To Reduce Infective Complications, Abortion And Preterm Delivery In Pregnant Women With Previous Preterm Delivery Unknown status NCT01152528 Phase 3
42 The Effect of Probiotics on the Immune Status, Diarrhea and Bacterial Vaginosis Cure Rate Among HIV Patients Unknown status NCT00536848 Phase 2, Phase 3 Metronidazole
43 Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community Unknown status NCT00124878 Phase 3
44 Performance Proof of Product Developed to Detect Abnormal Vaginal pH Unknown status NCT01542606 Phase 3
45 Assessment of the Efficacy of POLYGYNAX® in the Empirical Treatment of Infectious Vaginitis Completed NCT02515656 Phase 3 POLYGYNAX®;GYNODAKTARIN®;Placebo
46 Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis Completed NCT00137371 Phase 3 PVC (daily for 21 days, 7 days off);PVC (twice weekly)
47 Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis Completed NCT03294538 Phase 3 Estrace® Cream;Generic Estradiol Cream;Vehicle Cream
48 A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ Completed NCT01867164 Phase 3 Gynoclin V;Vagitrol V
49 A Multi-Site Study Comparing Estradiol Vaginal Cream (0.01%) to Estrace® Cream (0.01%) in Postmenopausal Females With Atrophic Vaginitis Completed NCT02995694 Phase 3 Estradiol;Placebos;Reference
50 A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis Completed NCT02195986 Phase 3 Estradiol Vaginal Cream, 0.01%;Estrace® 0.01% cream;Placebo Vaginal Cream

Search NIH Clinical Center for Vaginitis

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cochrane evidence based reviews: vaginitis

Genetic Tests for Vaginitis

Anatomical Context for Vaginitis

MalaCards organs/tissues related to Vaginitis:

38
Testes, Uterus, Colon, Cervix, Placenta, Bone, Neutrophil

Publications for Vaginitis

Articles related to Vaginitis:

(show top 50) (show all 2651)
# Title Authors Year
1
Risk factors for stress urinary incontinence after native-tissue vaginal repair of pelvic organ prolapse. ( 29333601 )
2018
2
Inguinal Hyperhidrosis: Case Report of an Uncommon Cause of Vaginitis. ( 29421341 )
2018
3
Intensive vaginal dilation using adjuvant treatments in women with Mayer-Rokitansky-Kuster-Hauser syndrome: retrospective cohort study. ( 28960241 )
2018
4
Quality of life following vaginal reconstructive versus obliterative surgery for treating advanced pelvic organ prolapse. ( 29379997 )
2018
5
Response of lactating dairy cows with or without purulent vaginal discharge to gonadotropin-releasing hormone and prostaglandin F2I+. ( 29385599 )
2018
6
Implementation of vaginal cleansing prior to cesarean delivery to decrease endometritis rates. ( 29343134 )
2018
7
Predictors for dislodgment of vaginal pessary within one year in women with pelvic organ prolapse. ( 29290215 )
2018
8
Proanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment. ( 29325916 )
2018
9
Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence. ( 29196153 )
2018
10
Vaginal bleeding and a giant ovarian cyst in an infant with 21-hydroxylase deficiency. ( 29252197 )
2018
11
Endovascular treatment for the control of active vaginal bleeding from uterine cervical cancer treated with radiotherapy. ( 29448806 )
2018
12
Saccharomyces cerevisiae-based probiotic as novel anti-fungal and anti-inflammatory agent for therapy of vaginal candidiasis. ( 29380641 )
2018
13
Double mucosal flap for the reconstruction of transverse vaginal septum - A novel surgical approach using the vaginal septal tissue. ( 29204361 )
2018
14
Are previous episodes of bacterial vaginosis a predictor for vaginal symptoms in breast cancer patients treated with aromatase inhibitors? ( 29409388 )
2018
15
Tetraglochin cristatum (Britton) Roth: a medicinal plant from the Argentinean highlands with potential use in vaginal candidiasis. ( 29307753 )
2018
16
Microbial Culturomics Broadens Human Vaginal Flora Diversity: Genome Sequence and Description of Prevotella lascolaii sp. nov. Isolated from a Patient with Bacterial Vaginosis. ( 29447068 )
2018
17
Correction to: Association between vaginal bulge and anatomical pelvic organ prolapse during pregnancy and postpartum: an observational study. ( 29356859 )
2018
18
Clinical Predictors of Successful Vaginal Myomectomy for Prolapsed Pedunculated Uterine Leiomyoma. ( 29449196 )
2018
19
Painless vascular leiomyoma found after incision of the vaginal wall: A case report. ( 29359115 )
2018
20
<i>'Lactobacillus raoultii'</i> sp. nov., a new bacterium isolated from the vaginal flora of a woman with bacterial vaginosis. ( 29204281 )
2018
21
Bacterial vaginosis, human papilloma virus and herpes viridae do not predict vaginal HIV RNA shedding in women living with HIV in Denmark. ( 28569142 )
2017
22
Cervical Ectropion May Be a Cause of Desquamative Inflammatory Vaginitis. ( 28460993 )
2017
23
Characterization of virulence factors of vaginal and anal isolates of Candida albicans sequentially obtained from patients with vulvovaginal candidiasis in north-east Brazil. ( 28844452 )
2017
24
The relationship between fecal incontinence and vaginal delivery in the postmenopausal stage. ( 28913133 )
2017
25
Case of hydrocele testis caused by vaginalitis, a rare manifestation of immunoglobulinA G4-related disease. ( 28809065 )
2017
26
Trichomonas vaginalis is very rare among women with vaginal discharge in Podlaskie province, Poland. ( 28612378 )
2017
27
Effectiveness of intrauterine treatment with cephapirin in dairy cows with purulent vaginal discharge. ( 28043367 )
2017
28
A Rare Cause of Recurrent Vaginal Hydrocele: Herniating Mesenteric Hydatid Cyst. ( 28979358 )
2017
29
Overexpression of Candida albicans Secreted Aspartyl Proteinases 2 or 5 is not sufficient for exacerbation of immunopathology in a murine model of vaginitis. ( 28760935 )
2017
30
Aerobic vaginitis: no longer a stranger. ( 28502874 )
2017
31
Effects of intrauterine infusion of Escherichia coli lipopolysaccharide on uterine health, resolution of purulent vaginal discharge, and reproductive performance of lactating dairy cows. ( 28434752 )
2017
32
Successful Vaginal Delivery of Naturally Conceived Dicavitary Twin in Didelphys Uterus: A Rare Reported Case. ( 28929000 )
2017
33
Effect of the vaginal pessaries MelanizolAr and KlimedeksAr on the glycogen level in the vaginal tissue of rats on the background of experimental vaginitis. ( 28914070 )
2017
34
Clinical features and surgical procedures of congenital vaginal atresia-A retrospective study of 67 patients. ( 28915489 )
2017
35
Syndromic Diagnosis in Evaluation of Women with Symptoms of Vaginitis. ( 28210940 )
2017
36
The normal vaginal and uterine bacterial microbiome in giant pandas (Ailuropoda melanoleuca). ( 28454704 )
2017
37
Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal Treatment. ( 28174295 )
2017
38
Successful vaginal delivery at term after vaginal reconstruction with labium minus flaps in a patient with vaginal atresia: A rare case report. ( 28422365 )
2017
39
Clinical Validation of a Test for the Diagnosis of Vaginitis. ( 28937557 )
2017
40
Editorial Comment to Case of hydrocele testis caused by vaginalitis, a rare manifestation of immunoglobulin G4-related disease. ( 28809054 )
2017
41
Congenital vaginal atresia: A report of 39 cases in a regional Obstetrics and Gynecology Hospital. ( 29270755 )
2017
42
Effects of intrauterine infusion of Escherichia coli lipopolysaccharide on uterine mRNA gene expression and peripheral polymorphonuclear leukocytes in Jersey cows diagnosed with purulent vaginal discharge. ( 28434729 )
2017
43
Abdominal radical trachelectomy for vaginal cancer - A case report. ( 28664182 )
2017
44
Cervical cytopathological changes among women with vaginal discharge attending teaching hospital. ( 28469316 )
2017
45
Comparisons of vaginal flora patterns among sexual behaviour groups of women: implications for the pathogenesis of bacterial vaginosis. ( 29212588 )
2017
46
Vaginal vault prolapse in a patient with Mayer-Rokitansky-KA1ster-Hauser syndrome: a video case presentation. ( 28405713 )
2017
47
Laparoscopic Repair of Vaginal Evisceration after Abdominal Hysterectomy for Uterine Corpus Cancer: A Case Report and Literature Review. ( 28502966 )
2017
48
Urethral Diverticulum Presenting as a Large Vaginal Mass Complicating Pregnancy and Delivery. ( 29026065 )
2017
49
Vaginal metastasis of bladder urothelial carcinoma: Description of a case and revision of literature. ( 28679193 )
2017
50
Consider the Risk of Vesicouterine Fistula in the Event of Intermittent Fluid Vaginal Discharge after a Cesarean Section. ( 29090213 )
2017

Variations for Vaginitis

Expression for Vaginitis

Search GEO for disease gene expression data for Vaginitis.

Pathways for Vaginitis

Pathways related to Vaginitis according to GeneCards Suite gene sharing:

(show all 28)
# Super pathways Score Top Affiliating Genes
1 12.62 AR CXCL8 ESR1 ESR2 IL6
2
Show member pathways
12.57 ABCB1 CXCL8 IL1B IL6 PRF1
3
Show member pathways
12.03 CXCL8 IL1B IL6
4
Show member pathways
12 CXCL8 IL1B IL6
5
Show member pathways
11.96 AR EZR IL6
6 11.86 CXCL8 IL1B IL6
7 11.83 CXCL8 IL1B IL6
8 11.79 CXCL8 IL1B IL6
9 11.76 CXCL8 IL1B IL6
10 11.73 CXCL8 IL1B IL6
11 11.72 AR ESR1 ESR2
12
Show member pathways
11.68 AR ESR1 ESR2
13 11.67 CXCL8 IL1B IL6
14 11.63 CXCL8 IL1B IL6
15 11.57 CXCL8 IL1B IL6
16 11.45 CXCL8 IL1B IL6
17
Show member pathways
11.43 CXCL8 IL1B IL6
18 11.32 CXCL8 IL1B IL6
19 11.23 AR CXCL8 ESR2 IL1B IL6
20 11.19 CXCL8 IL1B IL6
21 11.12 CXCL8 IL1B IL6
22 11.05 ESR1 ESR2
23 10.99 ESR1 ESR2
24 10.9 CXCL8 IL6
25 10.9 CXCL8 EZR IL1B IL6
26 10.79 AR IL1B IL6
27 10.66 IL1B IL6
28 9.76 ESR1 ESR2

GO Terms for Vaginitis

Biological processes related to Vaginitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 negative regulation of cell proliferation GO:0008285 9.76 AR CXCL8 IL1B IL6
2 positive regulation of gene expression GO:0010628 9.67 AR EZR IL1B IL6
3 positive regulation of NF-kappaB transcription factor activity GO:0051092 9.58 AR IL1B IL6
4 cell-cell signaling GO:0007267 9.56 AR ESR2 IL1B SH2D1A
5 positive regulation of transcription, DNA-templated GO:0045893 9.55 AR ESR1 ESR2 IL1B IL6
6 intracellular estrogen receptor signaling pathway GO:0030520 9.43 ESR1 ESR2
7 mammary gland alveolus development GO:0060749 9.32 AR ESR1
8 steroid hormone mediated signaling pathway GO:0043401 9.13 AR ESR1 ESR2
9 positive regulation of DNA binding transcription factor activity GO:0051091 8.92 ESR1 ESR2 IL1B IL6

Molecular functions related to Vaginitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 ATPase binding GO:0051117 9.58 AR ESR1 EZR
2 steroid hormone receptor activity GO:0003707 9.54 AR ESR1 ESR2
3 nuclear receptor activity GO:0004879 9.33 AR ESR1 ESR2
4 estrogen receptor activity GO:0030284 9.32 ESR1 ESR2
5 estrogen response element binding GO:0034056 9.26 ESR1 ESR2
6 RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding GO:0038052 8.96 ESR1 ESR2
7 steroid binding GO:0005496 8.8 AR ESR1 ESR2

Sources for Vaginitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....